Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2020
Reporting Period: The filing announces financial results for the three and twelve months ended December 31, 2019.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics are available in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms that results for the periods ended December 31, 2019, were announced.
Guidance, Outlook, and Management Commentary
Management Action: The company issued a press release on February 26, 2020, and scheduled a conference call for 8:00 AM EST on the same date to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2019.
- Verify the details of the conference call held on February 26, 2020, for management commentary on year-over-year performance.
- Confirm whether the press release contains updated forward-looking guidance or outlook statements.
- Check for any specific risk factors or contingencies disclosed in the full press release text.